Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs Enoxaparin to Prevent Venous Thromboembolism After Colon and Rectal Cancer Surgery
IRCT20260522069491N1Phase 3Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of rivaroxaban in ascending colon cancer, transverse colon cancer, colon cancer and 4 more (2 arms), sponsored by Tehran University of Medical Sciences. Started Jul 2026; status: recruiting.
02
Drugs
rivaroxaban
03
Conditions
ascending colon cancertransverse colon cancercolon cancersigmoid colon cancerrectal cancer
Beyond the preview
Go deeper on IRCT20260522069491N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260522069491N1.